New hope for kids with UC: Long-Term drug shows promise
NCT ID NCT02632175
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study looked at the long-term safety of a drug called adalimumab in children with ulcerative colitis, a disease that causes inflammation in the colon. 59 children who had already completed a previous study took the drug for up to 2 years. The goal was to see if it was safe and helped control symptoms like diarrhea and bleeding. The drug helped many children achieve remission, but it is not a cure—they need to keep taking it to manage the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arnold Palmer Hospital /ID# 147295
Orlando, Florida, 32806, United States
-
Centrum Zdrowia MDM /ID# 147280
Warsaw, Masovian Voivodeship, 00-189, Poland
-
Disc_Barts Health NHS Trust - The Royal London Hospital /ID# 147290
London, Greater London, E1 2ES, United Kingdom
-
Duplicate_The Royal Free London NHS Foundation Trust /ID# 147292
London, Greater London, NW3 2QG, United Kingdom
-
Gabinet Lekarski Bartosz Korcz /ID# 147281
Rzeszów, Podkarpackie Voivodeship, 35-210, Poland
-
Hospital Universitario Vall d'Hebron /ID# 147288
Barcelona, 08035, Spain
-
Instytut Centrum Zdrowia Matki Polki /ID# 169017
Lodz, Łódź Voivodeship, 93-338, Poland
-
Juntendo University Hospital /ID# 147315
Bunkyo-ku, Tokyo, 113-8431, Japan
-
Kurume University Hospital /ID# 145710
Kurume-shi, Fukuoka, 830-0011, Japan
-
MNGI Digestive Health, P. A. /ID# 147294
Minneapolis, Minnesota, 55413-2195, United States
-
Mayo Clinic - Rochester /ID# 147304
Rochester, Minnesota, 55905-0001, United States
-
MultiCare Institute Health System /ID# 169005
Tacoma, Washington, 98405, United States
-
National Center for Child Health and Development /ID# 147312
Setagaya-ku, Tokyo, 157-8535, Japan
-
Univerzitna nemocnica Martin /ID# 147283
Martin, Žilina Region, 036 01, Slovakia
-
Uniwersytecki Szpital Dzieciecy w Krakowie /ID# 147279
Krakow, Lesser Poland Voivodeship, 30-663, Poland
-
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego /ID# 147310
Wroclaw, Lower Silesian Voivodeship, 50-369, Poland
Conditions
Explore the condition pages connected to this study.